Patent details

EP3341016 Title: METHODS AND COMPOSITIONS FOR IMMUNE PROTECTION AGAINST EXTRA-INTESTINAL PATHOGENIC E. COLI

Basic Information

Publication number:
EP3341016
PCT Application Number:
US2016048278
Type:
European Patent Granted for LU
Legal Status:
Unitary Effect Registered
Application number:
EP167606169
PCT Publication Number:
WO2017035181
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHODS AND COMPOSITIONS FOR IMMUNE PROTECTION AGAINST EXTRA-INTESTINAL PATHOGENIC E. COLI
French Title of Invention:
MÉTHODES ET COMPOSITIONS POUR UNE PROTECTION IMMUNITAIRE CONTRE E. COLI PATHOGÈNE EXTRA-INTESTINALE
German Title of Invention:
VERFAHREN UND ZUSAMMENSETZUNGEN ZUM IMMUNSCHUTZ GEGEN EXTRAINTESTINALE PATHOGENE E. COLI
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
06/07/2023
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
18/07/2023
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
07/06/2023
Unitary Effect Registration Date:
18/07/2023
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
24/08/2016
Grant date:
07/06/2023
EP Publication Date:
04/07/2018
PCT Publication Date:
02/03/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
07/06/2023
EP B1 Publication Date:
07/06/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
24/08/2036
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
31/05/2023
 
 

Name:
GlaxoSmithKline Biologicals S.A.
Address:
Rue de l'Institut, 89, 1330 Rixensart, Belgium (BE)

Name:
Janssen Pharmaceuticals, Inc.
Address:
1125 Trenton-Harbourton Road, Titusville, NJ 08560, United States (US)

Inventor

1

Name:
KOWARIK, Michael, Thomas
Address:
Switzerland (CH)

2

Name:
MALLY, Manuela
Address:
Switzerland (CH)

3

Name:
ABBANAT, Darren, Robert
Address:
United States (US)

4

Name:
YON, Patricia, Ibarra
Address:
Switzerland (CH)

5

Name:
GAMBILLARA, Veronica
Address:
Switzerland (CH)

6

Name:
HAUPTLE, Micha, Andres
Address:
Switzerland (CH)

7

Name:
KEMMLER, Stefan, Jochen
Address:
Switzerland (CH)

8

Name:
WETTER, Michael, Lukas
Address:
Switzerland (CH)

9

Name:
JACQUEMYN, Bert
Address:
Belgium (BE)

10

Name:
POOLMAN, Jan, Theunis
Address:
Netherlands (NL)

11

Name:
HERMANS, Peter, Wilhelmus, Maria
Address:
Netherlands (NL)

Priority

1

Priority Number:
201562209091 P
Priority Date:
24/08/2015
Priority Country:
United States (US)

2

Priority Number:
201562210655 P
Priority Date:
27/08/2015
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/02; A61K 39/00; C08B 37/00; A61K 39/108; A61P 31/04; A61K 47/64;

Publication

European Patent Bulletin

1

Issue number:
202323
Publication date:
07/06/2023
Description:
Grant (B1)

2

Issue number:
202328
Publication date:
12/07/2023
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
202332
Publication date:
09/08/2023
Description:
Unitary Effect Request Receipt

4

Issue number:
202333
Publication date:
16/08/2023
Description:
Unitary Effect Request Acceptance

5

Issue number:
202339
Publication date:
27/09/2023
Description:
Document reprinted after correction (B8, B9)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages